As the number of infections <i>I</i> in a given county increases, the variance in exponential growth rate, Var(Δ<i>I</i>/<i>I</i>), decreases as . by Calvin Pozderac (10451496)

Expression of Egln3 decreases tumor aggression, increases survival and normalizes glioma vascular architecture. by Vicki A. Sciorra (312082)

SF pretreatment inhibited the I/R induced decrease in the IRL thickness. by Hong Pan (8686)

MVEC microvessel formation is restricted in hydrogels exhibiting increased stiffness or decreased concentration of adhesive peptides. by Rebecca A. Scott (488956)

“…An unpaired student’s t-test detect statistical significance, *p<0.05 for 7.5 wt% hydrogels containing 3 mM RGD relative to either (<b>A, C-F</b>) 15wt% hydrogels containing 3 mM RGD or (<b>G, I-L</b>) 7.5wt% hydrogels containing 1 mM RGD.…”

Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension. by Alexandre Denoyer (160189)

“…<p><i>(A)</i> A single administration of CXCR3 antagonist (NBI-74330, 1 µM, 100 µL) induces a transient decrease in intraocular pressure (n = 10 in each group). …”

FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

“…<b>B)</b> Rho activity was measured using a Rhotekin binding assay at 70% confluence. The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”

Decrease in extracellular Zn²⁺ in the hippocampus by zinc chelators. by Atsushi Takeda (18203)

“…<p>Hippocampal slices were prepared 2 h after i.p. injection of vehicle (A, n = 7) or CQ (30 mg/kg, B, n = 5) into NER, and 3 h after i.p. injection of vehicle (C, n = 7) or TPEN (1 mg/kg, D, n = 8) into NER. …”

N100 amplitude decrease during 1 Hz-rTMS. by Christian Helfrich (297785)

“…<p>(<b>A</b>) N100 amplitude reduction during 1 Hz-rTMS (group mean values). …”

Apigenin decrease eosinophil infiltration in colonic tissues from HFD-mice. by Daniela Gentile (5089280)

Dopaminergic Neurodegeneration in the Mouse Is Associated with Decrease of Viscoelasticity of Substantia Nigra Tissue by Elisabeth G. Hain (542261)

“…The decrease in viscosity and elasticity in the SN was paralleled by a reduced number of neurons due to the MPTP-induced neurodegeneration. …”

PGE₂ decreases <i>Sost</i> expression. by Damian C. Genetos (325684)

Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice. by Milena Jović (6707702)

“…(E-H) In the FO-treated 5xFAD animals the decreased surface of the Aβ halo overlaps with the decreased incidence of swollen, dystrophic neurites.…”

Erythrocyte membrane beta-actin band decrease intensities in RTT patients. by Alessio Cortelazzo (543292)

Expression of HCMV US proteins by MSC decreases PBMNC proliferation and correlates with the levels of HLA-I. by Melisa A. Soland (162129)

Expression of human PON1 decreases superoxide levels in the gut of <i>D. melanogaster</i>. by Alejandro A. Pezzulo (138238)

Glucagon receptor (GcgR) antagonism decrease α-cell proliferation. by Zhuo Liu (357070)

Silencing AXL in human colon cancer cells does not decrease proliferation. by Diana J. Uribe (2201695)

Normalized pressure pain thresholds (PPTs) (mean ± SEM) at start, middle, end and 5 minutes after a standardized tourniquet test. by Jeanette Tour (10790855)

Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

“…<b>(B)</b> Combining low glucose, ketone supplementation, and HBOT resulted in a marked decrease in cell proliferation which was significant from control at all time points tested. …”

Induction of a VSG synthesis block leads to a decrease in clearance of surface-bound anti-VSG221 antibodies. by Jackie L. Y. Cheung (3365033)